TY - JOUR T1 - Telemedicine home CPAP titration and follow-up in the COVID-19 scenario JF - ERJ Open Research JO - erjor DO - 10.1183/23120541.00084-2022 SP - 00084-2022 AU - Jaume Bordas-Martinez AU - Neus Salord AU - Eva Fontanilles AU - Eliseo Prado AU - María Calvo AU - João Carmezim AU - Salud Santos AU - Carmen Monasterio Y1 - 2022/01/01 UR - http://openres.ersjournals.com/content/early/2022/06/16/23120541.00084-2022.abstract N2 - Obstructive sleep apnea (OSA) is a highly prevalent chronic disease associated with important comorbidities such as traffic accidents, cardiovascular and metabolic diseases and mortality, among others [1]. Continuous positive airway pressure (CPAP), a first-line therapy in moderate-severe OSA [2], has been proven successful in improving daytime sleepiness, quality of life, reducing traffic accidents [3], improving hypertension and paroxistical atrial fibrillation [4, 5]. However, 47% of successfully titrated patients abandon treatment within three years [5, 6]. Thus, early OSA and CPAP education with close follow-up is mandatory to achieve satisfactory CPAP compliance [6, 7]. In that context, telemedicine and telemonitoring through remote monitoring CPAP have become promising strategies [8, 9]. Recently, smartphone applications [10] and wearables [11] have been added as new suggested tools for improving CPAP compliance.FootnotesThis manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.Conflict of interests: Jaume Bordas-Martinez participated in the development of the smartphone application. However, this research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.Conflict of interests: Dr. Bordas-Martinez reports and Jaume Bordas-Martinez participated in the development of the smartphone application. However, this research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.Conflict of interests: Dr. Salord has nothing to disclose.Conflict of interests: Dr. Fontanilles Arbones has nothing to disclose.Conflict of interests: Dr. Prado Gala has nothing to disclose.Conflict of interests: Dr. Calvo Sánchez has nothing to disclose.Conflict of interests: Dr. Carmezim has nothing to disclose.Conflict of interests: Dr. Santos has nothing to disclose.Conflict of interests: Dr. Monasterio Ponsa has nothing to disclose. ER -